Literature DB >> 25693888

Hyaluronic acid-fabricated nanogold delivery of the inhibitor of apoptosis protein-2 siRNAs inhibits benzo[a]pyrene-induced oncogenic properties of lung cancer A549 cells.

Chung-Ming Lin1, Wei-Chien Kao, Chun-An Yeh, Hui-Jye Chen, Shinn-Zong Lin, Hsien-Hsu Hsieh, Wei-Shen Sun, Chih-Hsuan Chang, Huey-Shan Hung.   

Abstract

Benzo[a]pyrene (BaP), a component of cooking oil fumes (COF), promotes lung cancer cell proliferation and survival via the induction of inhibitor of apoptosis protein-2 (IAP-2) proteins. Thus knockdown of IAP-2 would be a promising way to battle against lung cancer caused by COF. Functionalized gold nanoparticle (AuNP) is an effective delivery system for bio-active materials. Here, biocompatible hyaluronic acid (HA) was fabricated into nanoparticles to increase the target specificity by binding to CD44-over-expressed cancer cells. IAP-2-specific small-interfering RNA (siRNAs) or fluorescein isothiocyanate (FITC) were then incorporated into AuNP-HA. Conjugation of IAP-2 siRNA into AuNPs-HA was verified by the UV-vis spectrometer and Fourier transform infrared spectrometer. Further studies showed that AuNP-HA/FITC were effectively taken up by A549 cells through CD44-mediated endocytosis. Incubation of BaP-challenged cells with AuNP-HA-IAP-2 siRNAs silenced the expression of IAP-2, decreased cell proliferation and triggered pronounced cell apoptosis by the decrease in Bcl-2 protein and the increase in Bax protein as well as the active form of caspases-3. The BaP-elicited cell migration and enzymatic activity of the secreted matrix metalloproteinase-2 were also substantially suppressed by treatment with AuNP-HA-IAP-2 siRNAs. These results indicated that IAP-2 siRNAs can be efficiently delivered into A549 cells by functionalized AuNP-HA to repress the IAP-2 expression and BaP-induced oncogenic events, suggesting the potential therapeutic application of IAP-2 siRNA or other siRNA-conjugated AuNP-HA composites to COF-induced lung cancer and other gene-caused diseases in the future.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25693888     DOI: 10.1088/0957-4484/26/10/105101

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  6 in total

1.  Two Methods of AuNPs Synthesis Induce Differential Vascular Effects. The Role of the Endothelial Glycocalyx.

Authors:  Daniel Alberto Maldonado-Ortega; Gabriel Martínez-Castañón; Gabriela Palestino; Gabriela Navarro-Tovar; Carmen Gonzalez
Journal:  Front Med (Lausanne)       Date:  2022-06-29

2.  Household inhalants exposure and nasopharyngeal carcinoma risk: a large-scale case-control study in Guangdong, China.

Authors:  Yong-Qiao He; Wen-Qiong Xue; Guo-Ping Shen; Ling-Ling Tang; Yi-Xin Zeng; Wei-Hua Jia
Journal:  BMC Cancer       Date:  2015-12-29       Impact factor: 4.430

3.  CS-PEI/Beclin-siRNA Downregulate Multidrug Resistance Proteins and Increase Paclitaxel Therapeutic Efficacy against NSCLC.

Authors:  Wangta Liu; Yu-Lun Lo; Chin Hsu; Yi-Ting Wu; Zi-Xian Liao; Wen-Jeng Wu; Yi-Jou Chen; Chieh Kao; Chien-Chih Chiu; Li-Fang Wang
Journal:  Mol Ther Nucleic Acids       Date:  2019-06-29

4.  Hyaluronan-Metal Gold Nanoparticle Hybrids for Targeted Tumor Cell Therapy.

Authors:  Vanessa Sanfilippo; Viviana Carmela Linda Caruso; Lorena Maria Cucci; Rosanna Inturri; Susanna Vaccaro; Cristina Satriano
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

5.  Inflammatory Modulation of Polyethylene Glycol-AuNP for Regulation of the Neural Differentiation Capacity of Mesenchymal Stem Cells.

Authors:  Huey-Shan Hung; Wei-Chien Kao; Chiung-Chyi Shen; Kai-Bo Chang; Cheng-Ming Tang; Meng-Yin Yang; Yi-Chin Yang; Chun-An Yeh; Jia-Jhan Li; Hsien-Hsu Hsieh
Journal:  Cells       Date:  2021-10-22       Impact factor: 6.600

6.  Extracellular synthesis gold nanotriangles using biomass of Streptomyces microflavus.

Authors:  Meysam Soltani Nejad; Mehrdad Khatami; Gholam Hosein Shahidi Bonjar
Journal:  IET Nanobiotechnol       Date:  2016-02       Impact factor: 1.847

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.